Originally published in the Stock Savvy Dad newsletter on August 18, 2026

Today I want to pull back the curtain a little and share three stocks that are currently on my watchlist and provide additional insight into how to potentially think about the market.

Please note, this is not a buy or sell recommendation list or financial advice. Always do your own research and make decisions that fit your own situation.

Let’s get into it.

​Travelers Insurance: Travelers is a name most people overlook because insurance companies aren’t exciting. But the numbers tell a different story. Travelers has outperformed the S&P 500 over the past three and five years and continues to do so in 2026.

What I like about the company is how they’re integrating AI into their underwriting and claims process. Most insurance companies tend to lag when it comes to technology. Travelers is ahead of the curve and the numbers reflect that. For a set it and forget it investor this one is worth a closer look.

​Cloudflare: Another name I like is Cloudflare. As of August 6th they had a standout earnings report, and the stock jumped 8% blowing past its 52-week high. Cloudflare sits in a unique position securing internet traffic and machine to machine communication, which is becoming increasingly important as AI scales. That said I tend to avoid buying companies at their peak. I’ve set a price target and am waiting for the right entry point. A good company at a bad price is a bad investment.

​Remitly Global: The final name on my watchlist is Remitly Global and it’s the one you most likely have never heard of. The global remittance market, money sent across borders, exceeds $900 billion a year and is rapidly shifting from cash agents and storefronts to digital apps.

Remitly is at the center of that shift. Their second quarter results showed revenue up 20% year over year, earnings surging from three cents to 93 cents per share, and free cash flow up 83% through the first six months of 2026. The old players in this space, companies like Western Union, are struggling to manage outdated infrastructure and Remitly is built for where this market is headed.

​Eli Lilly: One stock I currently own and am watching closely is Eli Lilly. I’m actively looking to buy more shares and that’s because it’s as close to a buy it and forget it stock as there is. As the maker of Mounjaro and Zepbound it sits at the center of the GLP-1 weight loss and diabetes drug market which Goldman Sachs projects could reach $95 billion by 2030.

Their patent protection runs well into the mid 2030s with additional protections potentially extending to 2041. And the pipeline behind it is strong. An oral weight loss pill is in development and another drug working across three hormonal pathways is in phase 3 trials. Any time it pulls back I’m adding more shares and letting them marinate.

Hopefully this gives you insight into ways of thinking about the market. Researching a company and telling a story about it, is a great framework to help you decide if it’s worth buying, selling, or holding. Dive deeper into some of these companies and see what story you uncover about them.

— Stock Savvy Dad
​Invest smarter, build wealth, be a savvy dad.